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Summary
We have examined the cell surface molecule CD44, which is 
attracting interest because of reports that isoforms are 
associated with metastasis. The prognostic value of CD44 
expression has yet to be assessed for a solid tumour.
Benign (59) and malignant (primary 61, metastatic 59) 
gastric tissues were examined with antibodies directed at 
epitopes common to known CD44 isoforms. Normal mucosa 
was CD44 negative. In atrophic gastritis and intestinal 
metaplasia expression was restricted to the epithelial cells of 
the basal glands and was positively correlated with an 
increased leucocyte infiltrate and with the expression of HU\ 
DR by mucosal cells. These observations suggest a role for 
chronic inflammation in the induction of CD44 expression on 
benign mucosa. No such association was observed between 
inflammatory infiltrate and CD44 expression on gastric 
tumours.
CD44 expression, observed in only 49% of primary tumours, 
was associated with distant metastases at time of diagnosis 
and, among 31 curatively resected patients, with tumour 
recurrence (p~ 0-0014) and increased mortality (p = 0-001) 
during follow-up averaging 17 months. When we used an 
antibody directed against the CD44 variant exon 9v, we found 
a good correlation between the expression of total CD44 and of 
exon 9v containing isoforms, and 9v expression in primary 
tumours was significantly and positively associated with 
tumour recurrence and mortality.
Lancet 1993; 3 4 2 :1 0 1 9 -2 2
Introduction
C D 44 is a highly glycosylated cell surface molecule which 
appears to be involved in cell-cell and cell-matrix 
interactions. 1-3 CD44 is a family o f molecules encoded by 
one gene but differing in the number and combination of 
variant exons inserted into the framework (“standard”) 
form .3,4 Interest has been aroused by the discovery that the 
expression of one isoform of CD 44 distinguished metastatic 
from non-metastatic adenocarcinoma cell lines in the rat.5 
Proof that CD44 itself has a role in metastasis came from the 
demonstration that transfection with cDNA encoding this 
isoform converted non-metastatic carcinoma and sarcoma 
rat cells into metastatic cells.5
Human tumours express a variety of CD44 isoforms6"10 
and a role for this molecule has been suggested in the 
development of metastatic potential in man—indeed, high 
C D 44 expression has been shown to correlate with tumour 
dissemination and poor prognosis in diffuse large-cell 
lymphoma.11 Gastric carcinoma seemed an appropriate 
malignancy in which to look at CD44 expression and 
progression in a solid tumour because the different 
histomorphological types differ both in their 
organotropism to distant metastases and in their 
prognosis. 12,13
Materials and methods
Tissue specimens
Gastric mucosa and primary tumour samples from 60 patients with 
previously untreated gastric cancer undergoing gastrectomy at the 
Klinikum Grosshadern, Munich, were obtained up to 30 min after 
surgical removal, snap frozen in liquid nitrogen, and stored at 
~ 80°C. From patients with advanced cancer, samples were also 
obtained from regional lymph-node metastases (32) and from 
distant metastases to liver (10) and omentum (17). Cryostat sections 
(5 p.m) of specimens from 1 patient were placed on the same slide to 
compare directly primary and metastatic tumours with normal.
Clinicopathological indices
All histopathological and prognostic factors were evaluated by 
pathologists on internationally established criteria. Benign mucosa 
was assessed for gastritis and intestinal metaplasia. Staining results 
in primary tumours were correlated with prognostic features, 
including tumour-node-metastasis (TNM ) staging, Borrmann, 
Lauren* and WHO classifications, grading* tumour localisation, 
tumour diameter, and lymphatic invasion.14 Since histology often 
varied within the same tumour the diagnosis was based on the 
dominant pattern.
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Monoclonal antibodies and immunoperoxidase staining
Monoclonal antibodies NKI-Pl (IgG13 ascites, diluted 1 in 1000)15 
and 25*32 (IgG13 supernatant, diluted 1 in 100)16 are directed 
against the CD44 standard form. CD44 9v expression was 
determined with FW11-24 (IgGl3 supernatant, diluted 1 in 50) 
(unpublished). Epithelial cells were identified with HEA125, 
directed against a 3 kD molecule common to simple epithelium 
(IgGl? diluted 1 in 100, Dako) and leucocytes with anti-CD45 
M.701 clone 2B4 (IgGi3 diluted 1 in 100; Dako). HLA DR
1019
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index No* CD44 expression
Positive Negative
P
Leucocyte Infiltrate 56 00003
Weak 2 20
Moderate, strong 30 4
HLA DR expression 55 00003
Positive 32 7
Negative 2 14
Gastritis 59 00002
Absent, superficial 1 20
Atrophic 33 5
Intestinal metaplasia 46 00003
Yes 21 2
No 7 16
£80 -
♦Variation in numbers reflects fact that not all information was available for every patient,
Table 1: CD44 expression In benign gastric mucosa correlated 
with hlstopathologlcal and prognostic Indices
expression was evaluated with L243 (IgG2a; ATCC) as undiluted 
culture supernatant. Isotype-matched myeloma proteins MOPC21 
(IgGi) and UPC 10 (IgG2a), both at 10 jxg/mL (Sigma), were 
negative controls.
Tissue sections were stained with an indirect immunoperoxidase 
technique.14 The percent of CD44, CD44 9v, and HLA DR  
positive epithelial cells was estimated together with HEA125 
expression pattern on consecutive sections. The degree of 
leucocyte infiltration was judged by the proportion of cells in the 
section that were CD45 positive; weak =  single dispersed cells 
between the glands, moderate =  under 50% of the cells 
accumulated in the lamina propria between the glands, 
strong = over 50% of the cells accumulated in the lamina propria 
between the glands.
Stat/st/cai analysis
The correlation between CD44 expression and clinicopathological 
indices was analysed by Fisher’s exact test. Correlation between 
the fraction of CD44 positive epithelial ceils in gastric mucosa and 
autologous primary tumours and in primary and autologous 
metastatic lesions was assessed by the Spearman rank correlation 
coefficient. The same test was used to correlate CD44 and CD44 9v 
expression in individual tissues. Overall survival rates were 
calculated by the Kaplan-Meier method, and for differences 
between curves the p value was calculated by logrank test.
R e s u lt s
CD44 in benign gastric mucosa
Despite strong reactivity of a wide variety of different cell 
types, CD44 expression on epithelial cells was seen only in 
34 (58%) of the 59 samples o f benign gastric mucosa. 
Expression was restricted to the gastric glands near the 
muscularis mucosae and extending up the basal third of the 
mucosa, the area where epithelial cells also express the 
HNK-1 (CD57) epitope. 17 Although the fraction of positive 
glands varied (from below 10% to above 80%), CD44 
expression was never observed on the upper part of the 
glandular area near the gastric pits, on the epithelium lining 
the pits, or at the luminal surface»
CD44 expression on glandular cells was associated with 
moderate or strong leucocyte infiltration (table 1 ). Pits, 
however, were CD44 negative even in the presence of 
strong leucocyte infiltration. With two exceptions, CD44- 
positive gastric mucosa also expressed H LA DR, indicating 
activation of epithelial cells. In contrast to the spatially 
restricted pattern of CD44 expression, HLA D R  positive 
cells were found throughout the mucosal cells, from the 
basal part of the glands up to the epithelial surface.
These histological observations suggest that CD44 
expression on benign mucosa is associated with 
inflammation. A significant correlation was seen between
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Figure 1: CD44 expression In gastric mucosa and in autologous 
primary tumours in 51 Individual patients
Correlation not significant (Spearman's r=  0 019 , p = 0-45).
the presence of CD44 positive glandular cells and both 
atrophic gastritis and intestinal metaplasia, a condition 
always accompanied by atrophic gastritis. Specimens 
classified as normal or as only superficial gastritis were 
CD44 negative (table 1 ).
CD44 in primary gastric cancer
CD44 expression was observed in 30 (49%) of 61 primary 
gastric carcinomas. The fraction of CD44 positive cells 
ranged from 15% to more than 80%. However, leucocyte 
infiltration was not associated with CD44 positive tumours 
and co-expression of CD44 and HLA DR antigens was not 
found (table 2 ).
Despite a correlation between CD44 in primary tumours 
and autologous gastric mucosa (table 2 ), there was no 
correlation between the extent of CD44 expression in the 
two specimens (figure 1 ). 14 patients with CD44 positive 
tumours had negative mucosae and 17 patients with CD44 
negative tumours had positive mucosae.
CD44 expression was correlated with tissue 
differentiation (Lauren and WHO classifications). 
Differentiated tumours with glandular structures were 
more often CD44 positive than were undifferentiated 
carcinomas consisting of diffusely arranged tumour cells 
(table 2). Evaluation of other prognostic factors (table 2) 
revealed a significant correlation only between CD44 
expression and M-stage. Patients with distant métastasés 
apparent at the time of surgery had CD44 positive primary 
tumours more often than patients without detectable 
distant métastasés.
CD44 expression in metastatic lesions
CD44 expression was observed in 45 (76%) of 59 metastatic 
lesions (lymph node 32, liver 10, omentum 17) but no 
differences in CD44 expression were found for metastatic 
lesions at the three locations. As in the primary tumours no 
correlation was found between CD44 expression and 
leucocytes (p =  0*09), and there was no co-expression of 
CD44 and HLA DR antigens (p = 0*32).
In most cases CD44 positive métastasés derived from 
patients with CD44 positive primary tumours and CD44
1020 Vol 342 • October 23, 1993
T H E  LANCET
_ _ _______
Index No CD44 expression
Positive Negative
P
Leucocyte Infiltrate 58 0 12
Weak 21 17
Moderate, strong 7 13
HLA DR expression 55 0-58
Positive 9 9
Negative 19 18
CD44 expression on benign
gastric mucosa 51 004
Positive 16 17
Negative 14 4
Tissue architecture (Lauren) 61 0002
Intestinal 24 12 *
Diffuse 6 19
Tissue architecture (WHO)* 0004
Adenocarcinoma 22 11
Signet carcinoma 8 20
Cellular differentiation 61 064
61/2 10 10
G3/4/X 20 21
Tumour localisation 61 007
Cardia 12 6
Other 18 25
Tumour diameter 61 033
j£5 cm 9 12
>5 cm 21 19
Gross appearance 60 015
Borrmann Bl/2 18 13
83/4 12 17
Lymphatic vessel invasion 58 024
No 3 6
Yes 26 23
Depth of Invasion 61 045
Tl/2 17 16
T3/4 13 15
Nodal status 61 01
NO 3 8
Ni/2 27 23
Distant metastasis 61 002
MO 11 21
Ml 19 10
>80
♦Adenocarcinoma includes papillary, tubular, and mucinous adenocarcinomas and separates 
them from signet ring cell carcinomas.
Table 2: CD44 expression In primary gastric cancer correlated 
with histopathologic and prognostic Indices
negative métastasés derived from CD 44 negative primaries, 
but the correlation was not strong (Spearman's r = 0*349, 
p =  0*009) (figure 2). 10 patients with CD44 negative 
primary tumours had CD44 positive métastasés (15-80% 
positive cells) and 5 patients with CD44 positive tumours 
developed CD44 negative metastatic lesions.
Expression ofCD44 exon 9v
The antibodies used to examine CD44 expression react 
with several isoforms. To obtain information on CD44 
isoform expression in gastric epithelial cells, tissue sections 
still available from the non~isoform-specific studies were 
stained with a monoclonal antibody directed against the 
variant exon 9v. In contrast to total CD44 reactivity, 9v 
expression was restricted to epithelial cells. Lymphoid 
cells, connective tissue, endothelial cells, and smooth 
muscle cells were 9v negative.
31 benign gastric mucosa specimens and 35 primary and 
44 metastatic lesions were examined for reactivity with 
anti-CD44 9v. In all cases a good correlation was observed 
between reactivity with anti-CD44 and with anti-CD44 9 v 
in terms both of the number of positive lesions and the 
percent of positive cells (benign mucosae, r = 0*846, 
p = 0*0001;primary lesions, r =  0*863, p = 0*0001;metastatic 
lesions, r = 0-341, p =  0 01). Even so in some lesions, the 
fraction of 9v positive cells appeared to be less than the 
fraction of CD44 positive cells. This was especially true for
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Figure 2: CD44 expression In primary and In autologous 
metastatic tumours in individual patients
Closed circles represent lymph node, triangles liver, and open circles
omental metastases. Correlation significant (Spearman's r — 0 -3 4 9 , 
p — 0 009).
the metastatic lesions, where 3 CD44 positive lym ph-node  
metastases (over 70% cells) appeared to be 9v negative.
CD44 and prognosis
CD44 expression on primary gastric tumours was examined 
for its correlation with recurrence and with tumour'* 
induced mortality in 31 curatively resected patients. During 
follow-up of 6-39 months (mean 17 months) 10 of 13 
patients with CD44 positive primaries had local recurrence 
or distant metastases, while in CD44 negative patients 
tumour recurrence was less frequent (3/18, p  —0*001). 
Moreover, tumour-induced mortality was more frequent in 
CD44 positive patients (11/13 vs 2/18, p = 0 0 0 3 ). The 
Kaplan-Meier curves (figure 3) show that patients with 
CD44 positive primary tumours had a shorter survival time 
than those with CD44 negative tumours. Only 22 curatively 
resected patients were examined for CD44 9v expression, 
but the same association was seen between expression of 
this variant and survival (p =  0-005).
Time (mo)
Figure 3: Kaplan-Meier survival curves for 31 curatively 
resected gastric cancer patients, subdivided according to  
CD44 expression
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To compare the prognostic significance of CD44 
expression with other clinical indices3 we did multivariate 
regression analyses using the Cox hazard model. In this 
small group of patients C D 44 expression was an 
independent prognostic factor (p =  0 -0 0 0 2 ), over and above 
Borrmann classification (p =  0 *0 1 ) 3 T N M  staging 
(p = 0 '0 2 ) 5 grading (p =  0*04)5 and tumour diameter 
(p = 0*04).
correlation between CD44 expression and poor prognosis 
in solid tumours too.
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Discussion
We show here that in primary gastric carcinomas, 
expression of CD44 is significantly associated with distant 
metastases and3 in curatively resected patients^ with tumour 
recurrence and increased mortality. The use of antibodies 
that detect all CD44 isoforms to analyse the correlation 
between CD44 expression and prognosis was possible 
because, although CD44 isoforms are expressed on most 
cell types j normal gastric mucosa is CD44 negative and in 
benign mucosa it was expressed only when there was 
atrophic gastritis associated with a leucocyte infiltrate. 
These observations suggest that CD44 expression may be 
induced on the mucosal cells through direct or cytokine- 
mediated interaction with inflammatory ceils. Up- 
regulation of CD44 has been observed at other sites of 
chronic inflammation19 and can be induced on 
lymphocytes. 10,20*21 No such association between leucocyte 
infíltrate or cell activation and CD44 expression was 
observed for the carcinoma cells3 suggesting that different 
regulatory mechanisms are involved in CD44 expression in 
benign and malignant gastric tissues.
Immunohistochemical expression of the CD44 family 
was detected on only 49% of the primary carcinomas so we 
doubt if CD44 variant analysis7 will be a useful diagnostic 
marker for gastric cancer. Significant association was found 
between CD44 expression in primary tumours and distant 
metastases at the time of diagnosis (M l). Although a 
correlation was also found between CD44 and glandular 
structure, this may be in part a reflection o f the difficulty of 
identifying CD44 positive cells in diffuse tumours, where 
tumour cells are surrounded by CD 44-positive stroma and 
leucocytes. Most metastases from patients with CD44 
positive tumours were also CD44 positive. No association 
was found between CD44 expression and location of 
metastases, suggesting an equal involvement of CD44 in 
both lymph-borne and haematogenous spread of tumour.
An increase in the expression of variant CD44 isoforms 
has been associated with tumour progression in breast and 
colorectal carcinomas.7-9 Although the exact nature of the 
CD44 isoforms expressed on the gastric epithelial cells 
remains to be determined3 staining of several gastric tissue 
samples with an antibody directed specifically at the exon 
9v variant revealed a good correlation between expression 
of isoforms bearing this variant and total CD44. Moreover, 
as for total CD44, expression of 9v containing isoforms was 
closely associated with increased tumour recurrence and 
mortality. 9v has been identified in nine CD44 isoforms; 3 it 
is also present in the epithelial form (CD44E or CD44R1) 
expressed by normal keratinocytes and by a wide variety of 
carcinoma cells j22 and it is the major form o f CD44 which is 
up-regulated in tumours. 7-9 The finding o f a few strongly 
CD44 positive metastases which were 9v negative suggests 
that some tumours may express additional isoforms.
In diffuse large-cell lymphoma the expression o f CD44 
has been shown to correlate with reduced survival. 10,11 The 
clinical findings presented here provide evidence for a close
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